Recent pieces of evidence have suggested that indoleamine 2, 3-dioxygennase (IDO) activity is critical for the activity of FoxP3 Treg cells and various IDO inhibitors, including epacadostat, indoximod, are used in pre-clinical and clinical studies for various cancers other than neuroblastoma [191]. This evidence concerns the gene IDO1 and neuroblastoma.